user avatar
Amylyx
@AmylyxPharma
Ushering in a new era for treating diseases with high unmet needs. See our community guidelines here: amylyx.com/social-media-g…
Cambridge, MA
amylyx.com
Joined February 2019
432
Following
2,888
Followers
  • user avatar
    Amylyx
    @AmylyxPharma
    Oct 16, 2020
    Today, an overall survival analysis from the CENTAUR trial, which evaluated AMX0035 in people with ALS, was published in Muscle & Nerve. We're thankful to all study participants, their families and the clinicians who contributed to these meaningful results bwnews.pr/3nYGqVa
  • user avatar
    Amylyx
    @AmylyxPharma
    Sep 15, 2021
    We are thrilled to announce our intention to submit an NDA for AMX0035 for the treatment of #ALS to the U.S. FDA in the coming months. We will share any additional updates with the community as soon as we can.
    Square
    Amylyx Pharmaceuticals Announces Plan to Submit New Drug Application (NDA) for AMX0035 for the...
    From businesswire.com
  • user avatar
    Amylyx
    @AmylyxPharma
    Mar 9, 2021
    Today, we are excited to share news of our plans to submit a New Drug Submission for AMX0035 for the treatment of #ALS with Health Canada in the first half of 2021. This decision is based on the positive clinical data from the CENTAUR trial, and feedback from Health Canada.
  • user avatar
    Amylyx
    @AmylyxPharma
    Jun 13, 2022
    We are excited to share that Health Canada approved our new therapy for the treatment of amyotrophic lateral sclerosis, or #ALS. Read more at the link below. bit.ly/3zBeBue
    Designed pull-quote with headshots of Amylyx Co-CEOs and Co-Founders Justin Klee and Joshua Cohen
    Designed pull-quote from Norman MacIsaac, a person living with ALS
    Designed pull-quotes from neurologist Dr. Angela Genge
    Designed pull-quote with headshot of Chris Aiello, General Manager and Head of Canada at Amylyx
  • user avatar
    Amylyx
    @AmylyxPharma
    Sep 29, 2022
    #NEWS: We are thrilled to share that the @US_FDA has approved our new therapy. We’ve had the privilege of working closely with the broader community for nearly a decade and are grateful to all of those who continue to support our mission and our clinical programs.
    Learn more:
    From amylyx.com
  • user avatar
    Amylyx
    @AmylyxPharma
    Dec 29, 2021
    We are excited to share that the FDA has accepted for priority review the New Drug Application (NDA) for AMX0035 for the treatment of #ALS.
    Square
    Amylyx Pharmaceuticals Announces FDA Acceptance and Priority Review of New Drug Application (NDA)...
    From businesswire.com
  • user avatar
    Amylyx
    @AmylyxPharma
    Nov 2, 2021
    We are excited to share that we filed a New Drug Application (NDA) to the FDA for AMX0035 (PB/TURSO) for the treatment of #ALS. This submission represents a major milestone in our efforts to develop a potential new treatment option for the ALS community. bwnews.pr/3GJRBKv
  • user avatar
    Amylyx
    @AmylyxPharma
    Jun 14, 2021
    Today, we are pleased to share that we filed a New Drug Submission (NDS) to Health Canada for AMX0035 (PB-TURSO) for the treatment of #ALS. We look forward to continuing in our efforts to develop a potential new treatment option for ALS. bwnews.pr/3xe5paG
  • user avatar
    Amylyx
    @AmylyxPharma
    Sep 2, 2020
    We are excited to share the full results from our Phase 2/3 CENTAUR trial with the #ALS community in @NEJM. The data are a landmark for those living with the disease and we are looking forward to pursuing next steps for AMX0035. bwnews.pr/32OuM5j
  • user avatar
    Amylyx
    @AmylyxPharma
    Mar 18, 2022
    Today, we announced the launch of an Expanded Access Program (EAP) in the U.S. for our investigational #ALS therapy. Read more here: amylyx.com/media/amylyx-p…
  • user avatar
    Amylyx
    @AmylyxPharma
    Aug 29, 2022
    We at Amylyx, like so many people, are devastated by the loss of @SandyMorris333. Sandy's force of will was unstoppable - she was a lion - and her dedication to the highest principles and ethics while advocating for herself and others was unwavering.
    user avatar
    Sandy Morris
    @sandymorris333
    Aug 29, 2022
    And then there were 4. We are the Truest Most Beautiful Love Story. You won't 'move on' but you will move forward-w/all the love I was able to pour into your hearts w/the time allowed. It was my privilege & honor being your mom. Until we meet again my beloveds 💫 #MomIs #SandyIs
  • user avatar
    Amylyx
    @AmylyxPharma
    Apr 4, 2024
    Today we shared an update on our next steps, including a process we’ve initiated to remove our ALS treatment from the market and provide free access to therapy for those who wish to stay on. These decisions were informed by people who will be impacted and engagement with
    56K
  • user avatar
    Amylyx
    @AmylyxPharma
    Jun 1, 2021
    When @pjgreen was diagnosed with #ALS in 2018, he chose to dedicate his life to advocate for those affected by the disease. Along the way, Phil has impacted so many, including his friend Dan White who got tatted in honor of his close friend. #INKEDforALS bit.ly/3ySM6p5
  • user avatar
    Amylyx
    @AmylyxPharma
    May 5, 2020
    People with #ALS have no time to wait, which is why we’re investing every possible minute to move ahead and share the detailed results of the CENTAUR clinical trial as soon as we can. It’s our mission to do so efficiently and we will keep you informed on all developments.